Streptomyces WSH-28899 and application thereof in resisting tobacco mosaic virus
Through the metabolites of Streptomyces strain WSH-28899, the prevention and treatment problems of tobacco mosaic virus were solved, efficient viral inhibition and plant defense activation were achieved, and safe and environmentally friendly biopesticide applications were provided.
Patent Information
- Application Number
- CN202411025104.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to effectively prevent and control tobacco mosaic virus (TMV), and the use of chemical pesticides leads to environmental pollution, and lacks efficient and safe biological pesticides.
A Streptomyces strain WSH-28899 was developed, and its secondary metabolites have significant inhibitory activity on TMV, which can prevent viral invasion and curb its spread, and enhance disease resistance by activating the defense enzyme system of tobacco plants.
The fermentation broth of Streptomyces strain WSH-28899 has a passivation rate of 89.2% and a protection rate of 68.3% for TMV, which significantly destroys the physical structure of the virus and activates the disease-resistant defense mechanism of tobacco, providing an efficient biopesticide solution.
Smart Images

Figure CN118995477A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of microorganisms, and in particular to a strain of Streptomyces WSH-28899 and application thereof in resisting tobacco mosaic virus. Background Art
[0002] Tobacco mosaic virus disease is a plant disease that occurs widely around the world and causes huge economic losses every year. It is caused by the tobacco mosaic virus (TMV) invading the host through micro-wounds and causing infection. The virus can harm more than 800 plant species, including tobacco, cucumber, tomato, and pepper. After TMV infects tobacco plants in the field, young tobacco leaves are prone to bright vein symptoms, and the leaves are mottled with yellow and green. In severe cases, the leaves will be deformed, curled and twisted, and the plots that are particularly affected may even be completely destroyed. At present, the prevention and control measures for TMV mainly include planting disease-resistant varieties, intercropping and rotation, and chemical means such as controlling aphids and pesticide control. However, due to a series of problems such as TMV's wide host, fast transmission speed, high genetic variability, complex infection, and difficulty in breeding disease-resistant varieties, there is currently no effective drug for the prevention and control of TMV. In addition, with the long-term and large-scale use of chemical pesticides, environmental pollution, pesticide residues and other problems have intensified, and the development of new, more efficient and safe biological pesticides has become an urgent need for the research and development of pesticides for the prevention and control of TMV.
[0003] Microbial pesticides are an important type of biological control pesticides. They are biogenic pesticides that use bacteria, fungi, viruses, protozoa or genetically modified microorganisms and their secreted metabolites that exist in nature as active ingredients to control diseases, insects, weeds, rodents and other harmful organisms. They can be used directly to control diseases and pests, or their metabolites can be used as new pesticides.
[0004] Actinomycetes are an important resource for the development of microbial pesticides. Actinomycetes are widely present in terrestrial and aquatic ecosystems. Due to their diversity and ability to produce new natural products with biological activity, they have become a group of microorganisms with great economic value. At present, 70% of the antibiotics widely used by humans are produced by various actinomycetes. Streptomyces, the most widely used and most promising genus among actinomycetes, has secondary metabolites that are widely used in agriculture, animal husbandry, medicine and other fields due to their structural diversity and biological activity. Streptomyces has great development potential in the biological control of TMV. However, in the current research on the screening of biocontrol bacteria for TMV, the involvement of Streptomyces is relatively scarce. At the same time, the separation of TMV antagonistic active substances in the screened excellent biocontrol strains and their mechanism of action also need to be further explored and excavated. Summary of the invention
[0005] In view of this, the present invention provides a strain of Streptomyces sp. WSH-28899 and its application in resisting tobacco mosaic virus. The secondary metabolites of the strain have significant inhibitory activity against TMV, which can not only effectively prevent the infection of the virus, but also effectively curb its further spread by significantly inactivating the activity of the virus. More importantly, the metabolites of the Streptomyces strain WSH-28899 of the present invention have a significant inhibitory effect on the proliferation of TMV in tobacco plants, strongly destroy the physical structure of TMV, and also enhance the activity of defense enzymes in the plant body. Therefore, the Streptomyces strain WSH-28899 has great application potential in the field of TMV and other related biological control.
[0006] The technical solution of the present invention is achieved in this way:
[0007] In the first aspect, the present invention provides a Streptomyces strain WSH-28899, which is classified and named as Streptomyces sp., and was deposited in the China Center for Type Culture Collection on June 13, 2023, with a deposit number of CCTCC NO: M 20231013, and the deposit address is No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province.
[0008] In a second aspect, the present invention provides the use of the Streptomyces strain WSH-28899 in the preparation of anti-tobacco mosaic virus products.
[0009] In some preferred embodiments, the preparation is a microbial preparation.
[0010] In some preferred embodiments, the preparation method of the product comprises: inoculating strain WSH-28899, fermenting and culturing, and obtaining 2×10 8 CFU / ml of the original fermentation broth of the strain.
[0011] In some preferred embodiments, the method for preparing the product comprises:
[0012] The strain WSH-28899 was activated on ISP2 medium, and a 4 mm cork puncher was used to make a colony disc, which was inoculated into the seed medium and cultured at 150 r / min and 28°C for 4 days to obtain the seed solution. The seed solution was transferred into the fermentation medium at a 10% V / V inoculation rate.
[0013] 150r / min, 28℃ shaking culture for 7d;
[0014] The ISP2 medium components include 10 g / L malt extract, 4 g / L yeast extract, 4 g / L glucose, and 20 g / L agar;
[0015] The seed culture medium components include 4.0 g / L glucose, 4.0 g / L yeast extract powder, and 10.0 g / L malt extract powder;
[0016] The fermentation medium components include 20.0 g / L glucose, 10.0 g / L soy peptone, 0.5 g / L magnesium sulfate, 0.5 g / L dipotassium hydrogen phosphate, 0.5 g / L potassium dihydrogen phosphate, 0.5 g / L ammonium sulfate, and 0.5 g / L calcium carbonate.
[0017] Furthermore, in some preferred embodiments, the preparation method of the product further comprises: centrifuging the original fermentation liquid of the strain at 5000 r / min for 10 min to remove the precipitate and prepare the fermentation supernatant of the extracellular metabolites, that is, obtaining the anti-TMV active substance.
[0018] In a third aspect, the present invention further provides a product for resisting tobacco mosaic virus, wherein the active ingredients in the product include: the bacterial agent of the Streptomyces strain WSH-28899, and / or the metabolites of the Streptomyces strain WSH-28899.
[0019] In some preferred embodiments, the bacterial agent is a liquid bacterial agent or a solid bacterial agent.
[0020] In some preferred embodiments, the bacterial agent is a liquid bacterial agent, and the effective viable count of Streptomyces strain WSH-28899 in the bacterial agent is not less than 2×10 8 CFU / mL.
[0021] In some preferred embodiments, the bacterial agent is a solid bacterial agent, in which the effective viable count of Streptomyces strain WSH-28899 is not less than 3×10 10 CFU / g.
[0022] In a fourth aspect, the present invention provides the use of the Streptomyces strain WSH-28899 or the anti-tobacco mosaic virus product in resisting tobacco mosaic virus.
[0023] The present invention has at least the following beneficial effects:
[0024] The Streptomyces strain WSH-28899 provided by the present invention has significant inhibitory activity against tobacco mosaic virus, and the strain can effectively resist TMV. The half-leaf spot method was used to evaluate the passivation rate of its fermentation broth against TMV, which was as high as 89.2%. At the same time, in the application of preventing TMV infection, the protection rate reached 68.3%, which fully proved the efficient anti-TMV activity of the WSH-28899 fermentation broth. It was further verified by fluorescence observation that the metabolites of the Streptomyces strain WSH-28899 had a significant passivation effect on the TMV virus carrying the GFP marker, and could effectively curb the spread of the virus.
[0025] The present invention deeply explores the inhibitory mechanism of the fermentation liquid of Streptomyces strain WSH-28899 on TMV, and finds that the metabolites of Streptomyces strain WSH-28899 have a significant inhibitory effect on the proliferation of TMV in tobacco plants, and strongly destroy the physical structure of TMV while significantly inducing changes in the defense enzyme system in the heart-leaf tobacco, thereby activating the disease resistance mechanism of tobacco itself. After inoculation of TMV, the tobacco plants effectively prevent the large-scale replication and spread of TMV virus due to the resistance generated in the body, and achieve a significant antiviral effect. Therefore, Streptomyces strain WSH-28899 shows extremely high industrialization value and application potential in the application of anti-tobacco mosaic virus disease, and is expected to become an important part of the future agricultural green prevention and control system.
[0026] Biological Deposit
[0027] The Streptomyces sp. strain WSH-28899 provided by the present invention was deposited in the China Center for Type Culture Collection on June 13, 2023. The abbreviation of the depository unit name is CCTCC, the deposit number is CCTCC NO: M20231013, and the deposit address is No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.
[0029] Figure 1 The figure is a culture morphological characteristic diagram of Streptomyces WSH-28899 of the present invention, wherein the left figure is a front view of the strain, showing the surface morphological characteristics of the colony; the right figure is a back view of the strain, showing the morphological characteristics of the contact surface between the colony and the culture medium (the strain code W28 in the figure represents Streptomyces WSH-28899);
[0030] Figure 2 : is a phylogenetic tree of Streptomyces WSH-28899 of the present invention (the strain code W28 in the figure represents Streptomyces WSH-28899);
[0031] Figure 3 This is a diagram showing the passivation effect of Streptomyces WSH-28899 fermentation broth against TMV determined by the half-leaf spot method in Example 2 of the present invention, wherein: the left half leaf is treated with WSH-28899 fermentation broth + TMV crude extract, and the right half leaf is treated with clean water + TMV crude extract;
[0032] Figure 4This is a diagram showing the protective effect of Streptomyces WSH-28899 fermentation broth against TMV in the half-leaf spot method in Example 3 of the present invention, wherein: the left half leaf is treated with WSH-28899 fermentation broth, and the right half leaf is treated with clean water;
[0033] Figure 5 This is a diagram showing the passivation effect of the supernatant of the fermentation broth of Streptomyces WSH-28899 against TMV-GFP by fluorescence method in Example 4 of the present invention, wherein: the left half leaf is treated with the supernatant of the fermentation broth of Streptomyces WSH-28899 + TMV-GFP Agrobacterium liquid, and the right half leaf is treated with sterile water + TMV-GFP Agrobacterium liquid;
[0034] Figure 6 This is a diagram of the proliferation effect of the supernatant of WSH-28899 fermentation broth against TMV-GFP identified by fluorescence method in Example 5 of the present invention, wherein: the right half lobe is treated with the "five-point" infiltration of the supernatant of the fermentation broth of Streptomyces WSH-28899, and the left half lobe is the control group;
[0035] Figure 7 The transmission electron micrographs of TMV of the supernatant of the fermentation broth of Streptomyces WSH-28899 before (left) and after (right) treatment in Example 6 of the present invention (the strain code W28 in the figure represents Streptomyces WSH-28899);
[0036] Figure 8 This is a graph showing the changes in the activities of four defense enzymes (PAL, PPO, POD and SOD) after the heartleaf tobacco pretreated with the supernatant of the fermentation broth of Streptomyces WSH-28899 in Example 7 of the present invention was inoculated with TMV (the CK group was treated with the supernatant replaced by clean water and was not inoculated with TMV, and the CK+TMV group was treated with the supernatant replaced by clean water and then inoculated with TMV) (the strain code W28 in the figure represents Streptomyces WSH-28899). DETAILED DESCRIPTION
[0037] In order to make the purpose, technical scheme and advantages of the present application clearer, the present application is further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described herein are only used to explain the present application and are not intended to limit the present application. The reagents not described separately in detail in this application are all conventional reagents and can be obtained from commercial sources; the methods not specifically described in detail are all conventional experimental methods and can be learned from the prior art. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by technicians in the technical field of the present invention. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not used to limit the present invention.
[0038] Example 1
[0039] 1. Morphological identification
[0040] Streptomyces WSH-28899 was streaked onto ISP2 medium (malt extract 10 g, yeast extract 4 g, glucose 4 g, agar 20 g, sterile water to 1 L, pH 7.2) as follows. Figure 1 As shown, after 7 days, the colonies of Streptomyces WSH-28899 were round, with abundant yellow-brown hyphae in the base and grayish white aerial hyphae.
[0041] 2. 16S rDNA sequence identification
[0042] The DNA of Streptomyces WSH-28899 was extracted according to the method of bacterial genomic DNA extraction kit (purchased from Beijing Quanshijin Biological Company). After extracting the total genomic DNA of the strain, PCR was performed using the 16S rDNA gene universal primers 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R (5′-GGTTACCTTGTTACGACTT-3′), and the product was sent to Shanghai Shenggong Bioengineering Technology Service Co., Ltd. for sequencing. The sequencing results showed that the 16S rDNA sequence of Streptomyces WSH-28899 was shown in SEQ ID NO.1. After the 16S rDNA sequence was subjected to BLAST analysis in the NCBI database, cluster analysis and phylogenetic tree construction were performed using MEGA7.0 software using the neighbor-joining method. The results showed that the strain WSH-28899 had the highest sequence homology with the genus Streptomyces (Streptomyces sp.), and had a close genetic distance, such as Figure 2 As shown, the strain WSH-28899 was determined to be an actinomycete of the genus Streptomyces.
[0043] 3. Preparation of Streptomyces WSH-28899 fermentation broth
[0044] The Streptomyces WSH-28899 preserved on the slant was activated on the ISP2 medium, and colony discs were made by punching with a 4mm puncher, and inoculated into the seed medium (glucose 4.0g / L, yeast extract powder 4.0g / L, malt extract powder 10.0g / L, pH 7.0). The liquid volume in a 500mL triangular bottle was 100mL, and the inoculation amount was 5 colony discs per bottle. The seed solution was obtained by shaking and culturing at 150r / min and 28℃ for 4 days. The seed solution was transferred into the fermentation medium (glucose 20.0 g / L, soy peptone 10.0 g / L, magnesium sulfate 0.5 g / L, dipotassium hydrogen phosphate 0.5 g / L, potassium dihydrogen phosphate 0.5 g / L, ammonium sulfate 0.5 g / L, calcium carbonate 0.5 g / L, pH 7.0) at a 10% (V / V) inoculum. 100 mL of the solution was placed in a 500 mL Erlenmeyer flask and shaken at 28 °C and 150 r / min for 7 days to obtain 2 × 10 8CFU / ml of Streptomyces WSH-28899 original fermentation broth, and also Streptomyces WSH-28899 liquid microbial agent.
[0045] 4. Preparation of Streptomyces WSH-28899 solid microbial preparation
[0046] The seed solution prepared in step 3 was inoculated with 10% (V / V) in a solid fermentation medium (70% bran, 20% corn flour, 5% glucose, 1% magnesium sulfate, 1% dipotassium hydrogen phosphate, 1% potassium dihydrogen phosphate, 1% ammonium sulfate, 1% calcium carbonate, mixed and stirred evenly with water ratio of 10:7.5), with a loading volume of 20%, and cultured at 28°C for 10 days to obtain an effective viable count of 3×10 10 CFU / g of WSH-28899 solid bacterial agent.
[0047] 5. Isolation of metabolites containing anti-TMV active substances
[0048] The original fermentation liquid of Streptomyces WSH-28899 prepared in step 3 was centrifuged at 5000 r / min for 10 min to remove the precipitate and prepare the fermentation supernatant of extracellular metabolites, which is the anti-TMV active substance.
[0049] The original fermentation broth of Streptomyces WSH-28899 prepared in the above steps was used as the fermentation broth of Streptomyces WSH-28899, and the fermentation supernatant containing the metabolites of anti-TMV active substances was also used in the corresponding steps of Examples 2-7.
[0050] Example 2
[0051] This example uses the half-leaf spot method to identify the indoor passivation effect of Streptomyces WSH-28899 fermentation liquid against TMV. The specific method is as follows:
[0052] 1. Preparation of TMV crude extract: Weigh fresh leaves of Nicotiana tabacum cv. K326 infected with TMV, mix and grind with phosphate buffer (10 mM, pH 7.2) at a ratio of 1:10 (w / v), filter with sterile gauze and take the supernatant as TMV crude extract.
[0053] 2. The fermentation liquid of Streptomyces WSH-28899 prepared in Example 1 and the crude extract of TMV were mixed in a ratio of 1:1, and allowed to stand for 30 min. An appropriate amount of corundum was evenly sprayed on the surface of the inoculated leaves of Nicotiana glutinosa L. The left half of the inoculated leaves of Nicotiana glutinosa L was rubbed with the mixed liquid. The right half of the inoculated leaves of Nicotiana glutinosa L was rubbed with the same volume of the mixed liquid of clean water and the crude extract of the virus as a control.
[0054] 3. After 15 minutes of inoculation, wash the leaves with clean water, repeat 3 times. Count the number of necrotic spots on the left and right half leaves 3 days after inoculation, and calculate the necrotic spot inhibition rate according to formula (1).
[0055] Inhibition rate (%) = (number of necrosis spots on the right half leaf - number of necrosis spots on the left half leaf) / number of necrosis spots on the right half leaf × 100% Formula (1)
[0056] Experimental results: Figure 3 As shown, the fermentation broth of Streptomyces WSH-28899 has a very obvious passivation effect on TMV, and the dead spot inhibition rate reaches 89.2%.
[0057] Example 3
[0058] This example uses the half-leaf spot method to identify the protective effect of Streptomyces WSH-28899 fermentation liquid against TMV. The specific method is as follows:
[0059] 1. The fermentation liquid of Streptomyces WSH-28899 prepared in Example 1 was applied to the left half of the inoculated leaves of Nicotiana tabacum, and the same volume of clean water was applied to the right half of the inoculated leaves of Nicotiana tabacum as a control.
[0060] 2. After 24 hours, the entire leaf of each treatment was rubbed with TMV.
[0061] 3. After 15 minutes of inoculation, wash the leaves with clean water, repeat 3 times. 3 days after inoculation, count the number of necrotic spots on the left and right half of the leaves, and calculate the necrotic spot inhibition rate according to formula (1).
[0062] Experimental results: Figure 4 As shown, the fermentation broth of Streptomyces WSH-28899 has a significant protective effect against TMV, and the necrosis inhibition rate reaches 68.3%.
[0063] Example 4
[0064] This example uses fluorescence method to identify the indoor passivation effect of Streptomyces WSH-28899 metabolites against TMV. The specific steps are as follows:
[0065] 1. Place TMV-GFP Agrobacterium culture in liquid LB medium containing 50μg / mL Spe and Rif, shake and culture at 28℃ and 220r / min for 24h. Centrifuge at 5000r / min at room temperature for 5min, discard the supernatant and keep the precipitate, resuspend the bacterial precipitate with sterile water, centrifuge, and repeat twice. Suspend the collected bacteria in the impregnation solution (containing 10mM MgCl2, 150μMAS, 10mM MES, pH5.7), and then place in a 28℃ incubator in the dark for 2-4h.
[0066] 2. Take the supernatant of the fermentation broth of Streptomyces WSH-28899 prepared in Example 1 (hereinafter referred to as supernatant) and mix it with the incubated TMV-GFP Agrobacterium bacterial solution (OD 600 1.0) of equal volume, mix well and let stand for 30 min.
[0067] 3. Use a 1 mL syringe without a needle to infiltrate the mixture onto the back of the left half of the inoculated leaf of Nicotiana benthamiana grown for 4-6 weeks. Use a mixture of sterile water and incubated TMV-GFP Agrobacterium solution to infiltrate the back of the right half of the inoculated leaf of Nicotiana benthamiana as a control. Repeat 3 times.
[0068] 4. After 3-5 days of light cultivation, use a portable long-wave ultraviolet lamp (LUYOR-3104NDT Inspection Lamps, wavelength 365nm) in a dark room to detect the green fluorescence (GFP) intensity of the infiltrated leaves and take pictures.
[0069] Experimental results: Figure 5 As shown in the figure, after 5 days of light culture, the right half of the Nicotiana benthamiana leaf infiltrated with a mixture of sterile water and TMV-GFP Agrobacterium solution showed obvious green fluorescence, while the left half of the Nicotiana benthamiana leaf infiltrated with a mixture of supernatant and TMV-GFP Agrobacterium solution showed almost no fluorescence. This shows that the metabolites of Streptomyces WSH-28899 have a very obvious passivation effect on TMV.
[0070] Example 5
[0071] This example uses fluorescence method to identify the effect of Streptomyces WSH-28899 metabolites on the proliferation of TMV-GFP. The specific steps are as follows:
[0072] 1. Select Nicotiana benthamiana with good growth and uniform growth, and inoculate the back of the left and right halves of the leaves with TMV-GFP Agrobacterium solution simultaneously according to the method in Example 4.
[0073] 2. After 24 hours, the "five points" of the right half leaf of Nicotiana benthamiana were infiltrated with the supernatant of the fermentation broth of Streptomyces WSH-28899 prepared in Example 1 (hereinafter referred to as the supernatant) using a 1 mL syringe without a needle to form a ring around the area previously infiltrated with TMV-GFP, and repeated three times.
[0074] 3. After 3-5 days of light culture, use a portable long-wave ultraviolet lamp in a dark room to detect the GFP intensity of the infiltrated leaves and take pictures.
[0075] Experimental results: Figure 6As shown, after 5 days of light culture, the brightness of the fluorescent spots after supernatant treatment was significantly weaker than that of the control group, indicating that the metabolites of Streptomyces WSH-28899 had a significant inhibitory effect on TMV proliferation.
[0076] As shown in the results of Examples 2-5, Streptomyces strain WSH-28899 has significant inhibitory activity against tobacco mosaic virus, and the strain can effectively resist TMV. The half-leaf spot method was used to evaluate the passivation rate of its fermentation broth against TMV, which was as high as 89.2%. At the same time, in the application of preventing TMV infection, the protection rate reached 68.3%, which fully demonstrated the efficient anti-TMV activity of WSH-28899 fermentation broth. Further verified by fluorescence observation method, the metabolites of Streptomyces strain WSH-28899 have obvious passivation effect on TMV virus carrying GFP marker, and can effectively curb the spread of the virus.
[0077] Example 6
[0078] In this example, the effect of Streptomyces WSH-28899 metabolites on TMV was detected by electron microscopy. The specific method is as follows:
[0079] The supernatant of the fermentation broth of Streptomyces WSH-28899 prepared in Example 1 (hereinafter referred to as supernatant) was mixed evenly with the crude TMV extract, allowed to stand for 30 minutes, negatively stained with 1% phosphotungstic acid (pH=6.7), and then placed under an electron microscope for transmission photography.
[0080] Experimental results: Figure 7 As shown, the untreated TMV particles are of normal size, while the TMV particles treated with the supernatant are broken into fragments and formed into shorter rods, indicating that the supernatant, i.e., the metabolites of Streptomyces WSH-28899, has a strong destructive effect on the physical structure of TMV particles.
[0081] Example 7
[0082] This example uses enzyme activity to detect the mechanism of action of Streptomyces WSH-28899 metabolites against TMV. The specific method is as follows:
[0083] 1. Select healthy heartleaf tobacco with uniform growth, set up three treatment groups including clean water, WSH-28899 fermentation liquid supernatant (hereinafter referred to as supernatant) and TMV crude extract, each treatment has 10 tobacco plants, and repeated 3 times.
[0084] 2. Take 200ul of the WSH-28899 fermentation liquid supernatant prepared in Example 1 and apply it to the whole heart leaf tobacco leaf, apply it twice, with an interval of 1d, and rub and inoculate TMV virus particles 24h later. The other two treatment groups are the CK group in which the supernatant is replaced with the same volume of clean water and TMV is not inoculated, and the CK+TMV group in which the supernatant is replaced with the same volume of clean water and TMV crude extract is inoculated. Samples were taken from the top leaves of tobacco at 1, 2, 3 and 4 days after inoculation of TMV, and stored at -80°C after quick freezing in liquid nitrogen.
[0085] 3. According to the instructions of phenylalanine ammonia lyase (PAL), polyphenol oxidase (PPO), peroxidase (POD) and superoxide dismutase (SOD) kits (purchased from Nanjing Jiancheng Bioengineering Institute), the changes in the contents of PAL, PPO, POD and SOD in tobacco leaves were detected.
[0086] Experimental results: After two treatments with supernatant, the activities of four defense enzymes, PAL, PPO, POD and SOD, in the leaves were significantly higher than those in the CK group. This shows that the metabolites of Streptomyces WSH-28899 activate the activity of defense enzymes in the leaves and significantly improve the disease resistance of tobacco.
[0087] From the results of Examples 6-7, it can be seen that the metabolites of Streptomyces strain WSH-28899 have a significant inhibitory effect on the proliferation of TMV in tobacco plants, strongly destroying the physical structure of TMV while also significantly inducing changes in the defense enzyme system in heartleaf tobacco, thereby activating tobacco's own disease resistance mechanism. After inoculation with TMV, tobacco plants effectively prevent the massive replication and spread of TMV virus due to the resistance generated in the body, achieving a significant antiviral effect.
[0088] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. Streptomyces strain WSH-28899, It is characterized in that It is classified and named Streptomyces sp. and was deposited in the China Center for Type Culture Collection on June 13, 2023. The deposit number is CCTCC NO: M 20231013. The deposit address is No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province.
2. Use of the Streptomyces strain WSH-28899 according to claim 1 in the preparation of anti-tobacco mosaic virus products.
3. The use according to claim 2, It is characterized in that The preparation is a microbial preparation.
4. The use according to claim 2, It is characterized in that The preparation method of the product comprises: inoculating strain WSH-28899, fermenting and culturing, and obtaining 2×10 8 CFU / ml of the original fermentation broth of the strain.
5. The use according to claim 4, It is characterized in that The preparation method of the product comprises: The strain WSH-28899 was activated on ISP2 medium, and a 4 mm cork puncher was used to make a colony disc, which was inoculated into the seed medium and cultured at 150 r / min and 28°C for 4 days to obtain the seed solution; the seed solution was transferred into the fermentation medium at a 10% V / V inoculation rate, and cultured at 150 r / min and 28°C for 7 days; The ISP2 medium components include 10 g / L malt extract, 4 g / L yeast extract, 4 g / L glucose, and 20 g / L agar; The seed culture medium components include 4.0 g / L glucose, 4.0 g / L yeast extract powder, and 10.0 g / L malt extract powder; The fermentation medium components include 20.0 g / L glucose, 10.0 g / L soy peptone, 0.5 g / L magnesium sulfate, 0.5 g / L dipotassium hydrogen phosphate, 0.5 g / L potassium dihydrogen phosphate, 0.5 g / L ammonium sulfate, and 0.5 g / L calcium carbonate.
6. The use according to claim 4 or 5, It is characterized in that The preparation method of the product further comprises: centrifuging the original fermentation liquid of the strain at 5000 r / min for 10 minutes to remove the precipitate and prepare the fermentation supernatant of the extracellular metabolites.
7. A product against tobacco mosaic virus, It is characterized in that The active ingredients in the product include: a bacterial agent containing the Streptomyces strain WSH-28899 according to claim 1, and / or metabolites of the Streptomyces strain WSH-28899.
8. The product according to claim 7, It is characterized in that The bacterial agent is a liquid bacterial agent or a solid bacterial agent.
9. The product according to claim 7, It is characterized in that Including the following a1) or a2): a1) The bacterial agent is a liquid bacterial agent, and the effective viable count of Streptomyces strain WSH-28899 in the bacterial agent is not less than 2×10 8 CFU / mL; a2) The bacterial agent is a solid bacterial agent, and the effective viable count of Streptomyces strain WSH-28899 in the bacterial agent is not less than 3×10 10 CFU / g.
10. Use of the Streptomyces strain WSH-28899 according to claim 1 or the product according to any one of claims 7 to 9 in resisting tobacco mosaic virus.
Citation Information
Patent Citations
Streptomyces sp. strain and application thereof for preparing formulation for inhibiting plant virus diseases
CN102337239A
StreptomycesYunnanensis var daliensis and fermentation broth and application thereof
CN103805527A
Microorganism for controlling plant virus, plant virus-controlling agent composed of the same and method for controlling plant virus by using the same
JP2005000145A
